{"id": "GjPD0WkBST", "number": 7307, "cdate": 1758015025506, "mdate": 1759897860832, "content": {"title": "Ethical Dialogue Modeling: Dual-Phase Prompt Design for Safety-Constrained Mental Health Language Models", "abstract": "We introduce Ethical Dialogue Modeling (EDM), a two-stage architecture for safety-constrained clinical mental health support. In EDM, natural-language inputs are first translated into structured semantic and risk representations that expose affective intensity, therapeutic needs, and graded hazard estimates. These representations then condition a protocol-aware generation stage that enforces domain-specific safeguards and ethical constraints so that responses remain therapeutically appropriate while avoiding potentially harmful content. We constructed a diagnostically calibrated dialogue repository and validated it through clinician-mediated verification to ensure clinical fidelity.\nHuman involvement in EDM is limited to data annotation and post-hoc validation, without direct participation in inference or decision-making. Our evaluation adopts a hybrid methodology that combines computational-linguistic measures, bias screening, and a five-dimensional clinical assessment spanning therapeutic alignment, empathetic congruence, contextual consistency, task utility, and safety adherence. Comparative experiments demonstrate marked gains over baseline systems in contextual adaptation, reduction of hazardous outputs, and alignment with clinician judgments.\nThe main contributions of this paper are threefold. First, we propose a stratified processing paradigm that separates risk assessment from therapeutic response synthesis and embeds layered safety protocols. Second, we present a unified evaluation framework that blends automated metrics with clinical oversight. Third, we establish practical design principles for ethically governed mental-health language systems and indicate future directions in cross-cultural adaptation and multimodal clinical decision support.", "tldr": "We propose a dual-phase prompt framework that enhances safety and therapeutic relevance in mental health language models.", "keywords": ["Therapeutic Dialogue Systems", "Large Language Models", "Safety-Constrained Prompt Design", "Contextual Risk Stratification", "Therapeutic Alliance Modeling", "Affective State Inference", "Clinical AI Safeguards"], "primary_area": "alignment, fairness, safety, privacy, and societal considerations", "venue": "ICLR 2026 Conference Submission", "pdf": "/pdf/66be09803fa720c6dab67bacddcd58c2e6c237ff.pdf", "supplementary_material": "/attachment/55f3f0db50b926fec48988ced1cb1effebc89371.zip"}, "replies": [{"content": {"summary": {"value": "This paper introduces Ethical Dialogue Modeling (EDM), a two-phase framework designed to make large language models safer and more clinically reliable for mental health dialogue. The authors separate the process into two explicit stages: first, the model analyzes user inputs to extract emotional tone, therapeutic needs, and graded risk levels; second, it generates responses under strict safety constraints using template-guided decoding and protocol-based safeguards.\n\nThe paper makes an empirical contribution through the creation of a clinically validated dialogue repository that integrates simulated and clinician-authored conversations. Evaluation combines automated linguistic measures with expert clinical judgments across five axes,  therapeutic alignment, empathy, contextual consistency, task utility, and safety adherence. Results show substantial improvements over standard prompting and RLHF-based systems: hazardous outputs drop by over 80%, empathy scores increase, and clinician-model agreement reaches Œ∫ = 0.82.\n\nThe work also includes an 8-week IRB-approved pilot trial with 120 participants, demonstrating clinically meaningful reductions in depression (BDI) and anxiety (GAD-7) scores and higher therapeutic alliance compared to control."}, "soundness": {"value": 3}, "presentation": {"value": 3}, "contribution": {"value": 3}, "strengths": {"value": "- The main strength is the system‚Äôs design. It is easy to follow, modular, and focused on safety, making it useful not only for mental-health chat but also for other sensitive areas.\n\n- A dual-phase design that explicitly separates (i) contextual parsing + risk scoring from (ii) safety-constrained generation, with clinician escalation for high-risk cases. This addresses a real gap in prior ‚Äúone-shot prompt‚Äù approaches. The workflow and constraints are spelled out (objective, routing, escalation), not just gestured at.\n\n- The paper reports detailed tests, including component ablations, stress tests, text-plus-audio trials, and an eight-week pilot with real users. The broad testing makes the results more believable and shows that the method can work in real settings."}, "weaknesses": {"value": "1- The main dataset includes about 1,000 dialogue sessions, with roughly 60% generated through simulation and only 40% based on clinician role-play. While this helps with diversity, it limits the realism of the interactions. The small size and synthetic nature of the corpus make the strong claims of ‚Äúclinical reliability‚Äù somewhat overstated. Larger and more diverse real-world data would be needed to validate those outcomes.\n\n2- Many of the mathematical expressions, such as the risk tuple, constrained decoding, routing distributions, and orthogonality terms, mainly serve to formalize what are essentially design choices or workflow descriptions. They make the paper look more technical but do not represent genuinely new algorithms or theoretical advances. Much of what is written in mathematical form could be described in plain language without loss of substance.\n\n3- Hazard class is chosen by calibrated cutoffs on a softmax risk vector; small calibration drift can flip LOW‚ÜîMEDIUM‚ÜîHIGH and change the route (self-serve vs clinician). The paper doesn‚Äôt show online calibration, confidence intervals, or drift monitoring for these thresholds\n\n5- A separate metaphor score ùëö gates early escalation; however, figures of merit beyond accuracy (e.g., false-positive rates across dialects) are not provided here. Over-triggering can increase unnecessary referrals and reduce usability."}, "questions": {"value": "1. How were the auxiliary modules (AffectNet, therapeutic-need classifier, and risk estimator) trained and validated? The paper does not specify data splits, loss functions, or optimization details, making it unclear how these components contribute to the overall performance.\n\n2. How robust is the constrained-decoding penalty in preventing unsafe outputs? Would a hard-constraint decoding or rule-based fallback provide stronger guarantees?\n\n3. The router‚Äôs training and optimization details are unclear. How is stability ensured when balancing helpfulness and safety costs?\n\n4. The paper notes over-referral in low-risk situations. Could the authors provide ROC or cost-sensitive analyses to show control over false positives?"}, "flag_for_ethics_review": {"value": ["No ethics review needed."]}, "rating": {"value": 6}, "confidence": {"value": 4}, "code_of_conduct": {"value": "Yes"}}, "id": "Yvzs8kbadT", "forum": "GjPD0WkBST", "replyto": "GjPD0WkBST", "signatures": ["ICLR.cc/2026/Conference/Submission7307/Reviewer_VbaF"], "nonreaders": [], "readers": ["everyone"], "writers": ["ICLR.cc/2026/Conference", "ICLR.cc/2026/Conference/Submission7307/Reviewer_VbaF"], "number": 1, "invitations": ["ICLR.cc/2026/Conference/Submission7307/-/Official_Review", "ICLR.cc/2026/Conference/-/Edit"], "domain": "ICLR.cc/2026/Conference", "tcdate": 1761858201465, "cdate": 1761858201465, "tmdate": 1762919422542, "mdate": 1762919422542, "parentInvitations": "ICLR.cc/2026/Conference/-/Official_Review", "license": "CC BY 4.0", "version": 2}, {"content": {"summary": {"value": "The work addresses a critical and much-needed topic: the use of AI in mental health. The paper introduces Ethical Dialogue Modeling (EDM), a **hierarchical two-stage framework** that separates explicit risk representation from therapeutic response generation and embeds operational safety protocols end-to-end. It proposes a hybrid evaluation protocol that combines algorithmic indicators with clinician oversight to better reflect therapeutic standards and ensure clinical relevance. The work constructs and validates a diagnostically informed dialogue repository designed for safety-aware model development and to enable evaluation of figurative and culturally diverse language. Through architectural analyses, the paper demonstrates that domain-aware configurations enhance contextual adaptation and yield significant resource savings in clinical workflows."}, "soundness": {"value": 3}, "presentation": {"value": 3}, "contribution": {"value": 3}, "strengths": {"value": "1- Discussing a critical and much-needed topic ‚Äî the use of AI in mental health ‚Äî where not many works propose concrete, deployable approaches; the paper explicitly targets \"language-model deployment in psychological support settings‚Äù.\n\n2- Proposing a novel framework to enable the safe use of LLMs in mental health; EDM ‚Äúseparates contextual interpretation from safety-constrained response generation,‚Äù enabling explicit risk representation, template-guided synthesis, and conservative escalation when uncertainty or severe risk is detected.\n\n3- Conducting multiple analyses for safety validation, prompting evaluations, operational examples, algorithmic verification measures, expert assessments, and longitudinal outcomes to evaluate EDM and including adversarial stress tests, multimodal trials, ablations, clinician adjudications, and a longitudinal pilot.\n\n4- Developing culturally adaptive protocols that generalize figurative-language detection and therapeutic framing across diverse contexts; the roadmap commits to developing culturally adaptive protocols that generalize language detection and therapeutic framing across diverse contexts.\n\n5- Proposing Hazard Prevention Rate (HPR), plus ablations and multimodal effects (text vs. text+audio), and architectural profiling (throughput/latency/fidelity) to provide broader empirical characterization than typical safety-only work."}, "weaknesses": {"value": "1- The paper is hard to read and follow: sections drift, key terms appear before they are defined, and methods/results are interleaved.\n\n2- The dataset structure is not clear, and the rationale for sample selection in each phase is missing. Specify splits, counts per category, selection criteria, inclusion/exclusion rules, and how each phase (simulation, role-play, evaluation) maps to the research questions.\n\n3- The methodology section has no citations. It‚Äôs unclear whether the results build on established metrics, evaluation criteria, or psychological foundations. This is concerning since the methodology should be built on a clear foundation.\n\n4- The framework and dataset are not released. Without code, prompts, metric definitions, and at least a de-identified sample, the community cannot reproduce or extend the work. State what will be released and under what license.\n\n5- Nsim = 600 simulated dialogues (constrained prompts) are not real conversations. In this domain, which limits ecological validity and could inflate performance. Clearly separate findings for simulated and naturalistic data, and provide a real-world test slice.\n\n6- The stress suite and prompting test set are author-curated, and release details are absent. This makes reproducibility and benchmark comparability unclear. Provide the full suite definitions, threat models, and release terms. Also, the stress tests raise the risk of overfitting to your own hazards. Demonstrate generalization on at least one external safety benchmark and report domain-shift performance.\n\n8- The 8-week pilot is promising but insufficient for durable clinical claims. Frame it in terms of feasibility/safety, report confidence intervals and adverse events, and avoid drawing efficacy conclusions without longer follow-up.\n\n9- Human-in-the-loop is inconsistent: the text says humans are limited to annotation/post-hoc validation, yet it also routes high-risk cases to clinician-grade pathways. Clarify whether clinicians intervene at the time of inference/triage, the thresholds for escalation, and handoff procedures.\n\n10- ‚ÄúFidelity‚Äù is undefined. Readers cannot interpret the results without a clear definition of the metric (what it measures, how it‚Äôs computed, and why it matters clinically).\n\n11- The RCT status is ‚Äúregistered ‚Ä¶ under review,‚Äù which weakens pre-registration transparency. Provide the registration ID, primary/secondary outcomes, analysis plan, and masking details in the paper.\n\n12- Noise robustness is reported with BLEU-4, which does not capture conversational adequacy, intelligibility, or safety under noise. Add task-relevant human ratings or comprehension correctness under noisy conditions.\n\n**Format problems:**\n\n1- Contribution count is inconsistent: the introduction lists ‚Äúfour concrete contributions,‚Äù while the abstract claims ‚Äúthree.‚Äù Align the count and wording.\n\n2- A reference to ‚Äúthe algorithm above‚Äù (e.g., line 149) appears without any algorithm shown. Add the algorithm block or remove the pointer.\n\n3- Results and tables are shallow: limited comparative analysis, little error breakdown, and few ablations isolating components. Add per-attribute analyses, effect sizes with CIs, and cost/latency trade-offs.\n\n4- The abstract lacks a proper structure: no brief background or specific research question at the start. Begin with the problem context, then state the gap, your approach, and key outcomes."}, "questions": {"value": "Please check the Weaknesses and provide an answer for each point."}, "flag_for_ethics_review": {"value": ["Yes, Responsible research practice (e.g., human subjects, annotator compensation, data release)"]}, "details_of_ethics_concerns": {"value": "Line 946: The study adopted a pragmatic randomized controlled trial (RCT) design, chosen for its efficacy in evaluating interventions under real-world conditions while maintaining scientific rigor. This approach facilitates the assessment of both efficacy and effectiveness in clinical settings, balancing internal validity with external generalizability. The trial has been registered at ClinicalTrials.govunder review."}, "rating": {"value": 4}, "confidence": {"value": 4}, "code_of_conduct": {"value": "Yes"}}, "id": "RRRSfLX7co", "forum": "GjPD0WkBST", "replyto": "GjPD0WkBST", "signatures": ["ICLR.cc/2026/Conference/Submission7307/Reviewer_45xa"], "nonreaders": [], "readers": ["everyone"], "writers": ["ICLR.cc/2026/Conference", "ICLR.cc/2026/Conference/Submission7307/Reviewer_45xa"], "number": 2, "invitations": ["ICLR.cc/2026/Conference/Submission7307/-/Official_Review", "ICLR.cc/2026/Conference/-/Edit"], "domain": "ICLR.cc/2026/Conference", "tcdate": 1761929374084, "cdate": 1761929374084, "tmdate": 1762919422143, "mdate": 1762919422143, "parentInvitations": "ICLR.cc/2026/Conference/-/Official_Review", "license": "CC BY 4.0", "version": 2}, {"content": {"summary": {"value": "The authors propose EDM (Ethical dialogue modeling) in mental health settings, a two-stage framework that parses user utterances into risk representations (Phase I), then generates responses under safety constraints (Phase II). They seemingly constructed a dialogue corpus of 1,000 therapeutic conversations and evaluated EDM against three baselines on a test set (n=450) using BERTScore, empathy, safety, and harm rate metrics.\n\nLicensed clinicians rated 100 system responses on safety, appropriateness, and cultural sensitivity. A panel of clinicians evaluated the system on 25 high-stakes and 50 extreme edge-case scenarios. The authors also conducted an 8-week randomized controlled trial (N=120) comparing EDM to treatment-as-usual, measuring depression, anxiety, and therapeutic alliance outcomes. The system was benchmarked against three external datasets (CoSafe, PsySUICIDE, COUNSELINGEVAL) and evaluated on multimodal (text + audio) inputs."}, "soundness": {"value": 1}, "presentation": {"value": 2}, "contribution": {"value": 1}, "strengths": {"value": "## Strength 1\n\nThe paper addresses a genuine and timely clinical need for scalable mental health support for populations with access barriers. \n\n## Strength 2\n\nThe two-phase architecture (risk assessment decoupled from response generation) is intuitively sensible for therapeutic dialogue and provides a reasonable conceptual framework that could integrate safety constraints into generation to some extent.\n\n## Strength 3\n\nThe authors attempted to combine multiple evaluation modalities (automated metrics, clinician adjudication, longitudinal pilot, component ablations, external benchmark comparisons) rather than relying on a single metric. \n\n## Strength 4\n\nThe paper claims to include licensed clinicians in validation (N panel members, 8-week RCT with N=120) rather than purely algorithmic evaluation, which is appropriate for clinical applications. The authors also conduct a qualitative analysis of failure modes (metaphor misinterpretation, cultural bias, over-referral)."}, "weaknesses": {"value": "## Weakness 1 \n\nThe authors claim to address limitations in therapeutic LLMs but don't adequately discuss known failure modes like bias and symptom exaggeration documented in prior work (e.g., https://dl.acm.org/doi/10.1145/3715275.3732039 and https://openreview.net/forum?id=1pgfvZj0Rx#discussion). How does EDM specifically mitigate these established problems?\n\nAlso, the paper emphasizes localization and cross-cultural adaptation as future work, yet doesn't clarify how the current system performs across different cultural contexts or healthcare systems. What evidence supports clinical applicability beyond English-speaking settings?\n\n## Weakness 2\n\nThe dual-phase architecture combines standard components (affect detection, risk classification, constrained decoding) without clear novelty over existing therapeutic LLM work. What is the specific algorithmic advance beyond combining existing techniques?\n\nThe mathematical formulation (Eqs. 10‚Äì18) appears to add complexity without justified benefit (memory mechanisms and orthogonality penalties are borrowed from standard literature without ablation studies demonstrating their necessity). Adding much needed details to the conducted experiments would make the paper stronger. \n\n## Weakness 3\n\nThe discrete hazard class (Eq. 6) is defined algorithmically but lacks a clinically grounded rubric with verifiable criteria that could be explained to domain experts. What explicit criteria distinguish \"HIGH\" from \"MEDIUM\" risk, and who determined these? The paper states thresholds are \"calibrated\" but provides no actual threshold values, the process for setting them, or sensitivity analysis showing how different thresholds affect false negatives (critical for safety). How were œÑ_high and œÑ_med determined and validated? Why are high-risk and medium-risk categories measured separately rather than using a continuous risk score? What justifies this discretization?\n\n## Weaknes 4\n\nThe authors claim to solve cognitive bias (line 109) through \"clinician-supervised validation,\" but this looks like circular reasoning, as human clinicians have documented biases. What specific mechanisms prevent clinician bias from being amplified in your system? Also, the paper mentions \"bias screening\" in Section 3.2 with zero implementation details, methodology, or bias metrics reported. What bias assessment was actually conducted, and where are the results?\n\n## Weakness 5\n\nThe seemingly used dialogue corpus (n=1000: 600 simulated, 400 role-play) lacks any transparency: Where did the role-play sessions originate, who conducted and verified them, and what do \"constrained prompts\" mean? This is essential for assessing representativeness and quality. The 18.2% content exclusion rate in the safety filtering pipeline is mentioned without explanation of what was excluded or why. What types of content were filtered out, and could this bias the training data?\n\n## Weakness 6\n\nThe \"high-stakes scenarios\" (n=25) lack documentation of their source, who created them, what content they contain, and how quality was verified. Are these scenarios published or available for independent evaluation?\n\n## Weakness 7 \n\nThe three prompting baselines (P_COT, P_RLHF+, P_CLIN) are described in generic terms (\"standard chain-of-thought,\" \"clinical scaffolding\") but no actual prompts or implementation details are provided. How can anyone reproduce or critique your experimental setup? What exactly is the \"clinical scaffolding\" in P_CLIN, and which specific therapeutic protocols or evidence-based interventions does it incorporate? This is too vague to evaluate or replicate. What RLHF training procedure was used for P_RLHF+, what was the reward model, and how many human annotations were required? The description is insufficient.\n\n## Weakness 8 \n\nThe clinician panel is described only as having \"mean experience ¬µ_exp = 14.3 years\" with no information on panel size, geographic location, clinical specialization, or which countries' regulatory bodies licensed them. How representative is this sample?\n\n## Weakness 9 \n\nThe paper claims IRB approval for an 8-week RCT (N=120) but provides no IRB number, approval date, protocol registration link, or study location. Without these identifiers, the claimed human subjects research cannot be independently verified. Section G.9 vaguely mentions \"clinical partnerships and community outreach\" for recruitment but provides no specifics on study sites, inclusion criteria, or participant demographics. Where and how was this trial conducted?\n\nThe trial results (Table 6) show large effect sizes (d=1.24 for BDI, d=1.37 for GAD-7) compared to controls. What was the control condition exactly, and were there any baseline differences between groups?\n\n## Weakness 10 \n\nTable 2 reports multimodal efficacy but provides no error bars, confidence intervals, or statistical significance tests. Were differences between conditions statistically significant? Table 5 (n=50 extreme scenarios) reports percentages without uncertainty quantification or statistical tests. With such a small sample, how confident can we be in these results? Table 4 reports Cohen's Œ∫ but without confidence intervals or formal inter-rater agreement tests beyond point estimates. What are the 95% CIs?\n\n## Weakness 11\n\nNo actual prompts, threshold values, hazard classification rubric, or code are provided anywhere in the paper. This work is effectively non-reproducible as written (what materials will be made available and under what license)? The metaphor detector achieves 96.8% accuracy (line 363) but there's no description of the training dataset, test set, or validation procedure. Where was this component trained and evaluated? The paper claims to have constructed \"a diagnostically calibrated dialogue repository\" but provides no repository link, data release plan, or access information. Will this dataset be made public?\n\n## Weakenss 12\n\nThe paper compares EDM to automated baselines but not to human therapist performance in terms of accuracy, therapeutic alliance, or adverse outcomes. How does EDM compare to actual human clinicians on the same cases?\n\n## Weakness 13\n\nWho is \"the user\" in the deployed pipeline (the patient, a clinician, or both)? The application scenario remains unclear throughout the paper. What is the actual clinical workflow you envision? Was the system tested for sensitivity to patient demographic information (race, gender, socioeconomic status, etc.)? Such biases are well-documented in healthcare AI but no analysis is presented.\n\n## Weakness 14\n\nThe safety analysis is based on only n=25 high-stakes scenarios and n=50 extreme scenarios (both insufficient sample sizes for drawing robust conclusions about real-world safety). How was the representativeness of these edge cases validated? The paper claims \"emergency protocols activated for all critical-risk inputs (100%)\" but doesn't define what triggers an emergency or discuss false-positive rates for unnecessary escalation. Over-referral can desensitize users to legitimate warnings.\n\n## Weakness 15 \n\nImproving general clarity: The related work section is embedded in the introduction rather than presented as its own section, making it difficult to assess how this work positions relative to existing literature. Consider restructuring for clarity. This paper conflates novelty with complexity (many mathematical formulations add notation without proportional insight, see https://arxiv.org/abs/1807.03341 on mathy-ness). The work would benefit from clearer intuition for why each component is necessary."}, "questions": {"value": "I've embedded my questions into the weaknesses."}, "flag_for_ethics_review": {"value": ["Yes, Responsible research practice (e.g., human subjects, annotator compensation, data release)"]}, "details_of_ethics_concerns": {"value": "Insufficient information on used data sets and conducted human participant studies."}, "rating": {"value": 0}, "confidence": {"value": 5}, "code_of_conduct": {"value": "Yes"}}, "id": "pOE7XnyHAu", "forum": "GjPD0WkBST", "replyto": "GjPD0WkBST", "signatures": ["ICLR.cc/2026/Conference/Submission7307/Reviewer_Ao3W"], "nonreaders": [], "readers": ["everyone"], "writers": ["ICLR.cc/2026/Conference", "ICLR.cc/2026/Conference/Submission7307/Reviewer_Ao3W"], "number": 3, "invitations": ["ICLR.cc/2026/Conference/Submission7307/-/Official_Review", "ICLR.cc/2026/Conference/-/Edit"], "domain": "ICLR.cc/2026/Conference", "tcdate": 1762048532031, "cdate": 1762048532031, "tmdate": 1762919421853, "mdate": 1762919421853, "parentInvitations": "ICLR.cc/2026/Conference/-/Official_Review", "license": "CC BY 4.0", "version": 2}], "withdrawn": false}